ModerateDirect serotonin precursor, supplement (not registered as medicine in EU or US)×Selective serotonin reuptake inhibitors (SSRIs)
Updated · Methodology
Mechanism
Escitalopram selectively inhibits serotonin reuptake (Cipralex SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). 5-hydroxytryptophan (5-HTP) is the intermediate in the synthesis of serotonin from tryptophan, so the effects of the two substances on serotonin transmission add up. The Spanish escitalopram SmPC advises caution with serotonergic drugs and names triptans, opioids and tryptophan among them. It also reports cases of potentiated effects when selective serotonin reuptake inhibitors (SSRIs) were given with lithium or tryptophan (AEMPS). The US escitalopram label lists tryptophan among serotonergic drugs that raise the risk of serotonin syndrome, and its highlights state that use with tryptophan is not recommended (Lexapro label, US Food and Drug Administration, FDA). The escitalopram documents do not name 5-HTP, and as a food supplement it has no medicine label of its own. The US tranylcypromine label lists hydroxytryptophan among agents contraindicated with tranylcypromine because of serotonin syndrome (Parnate label, FDA).
Symptoms
The main risk of the combination is serotonin syndrome. The escitalopram SmPC reports it in rare cases in patients taking selective serotonin reuptake inhibitors (SSRIs) together with serotonergic drugs. A combination of agitation, tremor, myoclonus and hyperthermia may signal the syndrome (Cipralex SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The US escitalopram label adds hallucinations, delirium, coma, tachycardia, labile blood pressure, dizziness, sweating, flushing, rigidity, hyperreflexia, incoordination, seizures, nausea, vomiting and diarrhoea (Lexapro label, US Food and Drug Administration, FDA).
Management
The escitalopram documents do not name 5-hydroxytryptophan (5-HTP), so the level of risk rests on what they say about serotonergic drugs and tryptophan. Use escitalopram with caution together with serotonergic drugs, tryptophan included (Cipralex SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). If the combination is clinically warranted, tell the patient about the increased risk of serotonin syndrome. Monitor for its symptoms, particularly when escitalopram is started and when the dose goes up (Lexapro label, US Food and Drug Administration, FDA). If agitation, tremor, myoclonus and hyperthermia appear, stop escitalopram and the serotonergic agent at once and start symptomatic treatment (Cipralex SmPC, AEMPS). The highlights of the US label do not recommend escitalopram with tryptophan, the amino acid the body turns into 5-HTP (Lexapro label, FDA).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Lexapro (escitalopram) prescribing information (2023)– FDA label, Allergan, Inc., DailyMed setid 13bb8267-1cab-43e5-acae-55a4d957630a, revised 10/2023, sections 4, 5.2 and 7
- AEMPS: Ficha técnica de Cipralex 10 mg (escitalopram) (2026)– AEMPS CIMA, nregistro 65230, revisión 03/2026, secciones 4.3 y 4.5
- FDA: Parnate (tranylcypromine) prescribing information (2025)– FDA, DailyMed, Advanz Pharma, setid b72d8187-dfcc-4ea0-b5e9-c0be95b69a27, revised 07/2025, sections 4.1, 5.3, 5.9 and 7.1